Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.
Prenetics Global stock last closed at $1.47, down 2.65% from the previous day, and has decreased 85.24% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.74 percentage points. Prenetics Global stock is currently +18.55% from its 52-week low of $1.24, and -86.56% from its 52-week high of $10.94.
At the moment, there are 110.98M PRE shares outstanding. The market value of PRE is $163.14M. In the past 24 hours, 97,912 PRE shares were traded.
How to Buy Prenetics Global Stock
Wondering how to invest in Prenetics Global stock? Here's how.
Choose where to buy Prenetics Global stock: You need to choose an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Prenetics Global stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Fund your investment account: Pick your method of payment and add your info.
Analyze Prenetics Global stock: The Prenetics Global ticker symbol is PRE. Is Prenetics Global stock a good investment? Should you buy shares of PRE? How do PRE's underlying business fundamentals look? Do top analysts think Prenetics Global is a good buy? Why has PRE's stock price moved recently? (Hint: Our stock research website can help you figure out if PRE is a good stock to buy).
Execute your PRE purchase: Decide if you will purchase PRE shares at the current market price or use a limit order to purchase PRE stock at a given price.
Get key alerts regarding your PRE position: Create a watchlist to keep tabs on your new investment in Prenetics Global shares.
Step 1: Choose where to buy Prenetics Global stock
You need an online brokerage account to access the NASDAQ market and buy PRE stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now.
After you have selected the best place to buy Prenetics Global stock, it's absolutely critical to research their stock prior to investing, so you actually understand the risk as well as the upside.
Overview of key PRE info
PRE Price
$1.47
1w %
-4.55%
1y %
-85.24%
5y %
N/A
P/E
-0.1x
P/B
0.79x
P/S
0.23x
PEG
N/A
Revenue
$441.84M
Earnings
-$358.34M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$163.14M
Next Earnings
Mar 1, 2023
Next Dividend
N/A
PRE Due Diligence Checks
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on PRE's stock page.
Is PRE stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PRE's fair value.
Using relative valuations ratios:
PRE could be undervalued based on its P/B ratio of 0.79x, relative to Diagnostics & Research industry P/B ratio of 4.54x
You can access additional valuation analysis on PRE's stock here.
PRE Financial Health Overview
Passed Financial Due Diligence Checks:
PRE has a low debt to equity ratio of 0.3.
There are more short-term assets than short-term liabilities on the PRE balance sheet.
There are more short-term assets than long-term liabilities on the PRE balance sheet.
Failed Financial Due Diligence Checks:
PRE profit margin has gone down from N/A to -81.1% in the past year.
Is Prenetics Global stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 Wall Street analysts who give recommendations on PRE, the consensus analyst rating on Prenetics Global is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent PRE Analyst Recommendations
Ross Osborn, a top 44% analyst from Cantor Fitzgerald initiates coverage on PRE with a strong buy rating and announces their PRE price target of $7.00, on Jan 18, 2023.
Jeffrey Cohen, a bottom 1% analyst from Ladenburg Thalmann initiates coverage on PRE with a strong buy rating and announces their PRE price target of $15.00, on May 2, 2022.
No, Prenetics Global doesn't provide an income stream by paying out dividends.
PRE Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your PRE purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a specific dollar amount, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you require more help investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Prenetics Global share?
As of Feb 3, 2023, it costs $1.47 to buy one share of Prenetics Global stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.74, you can buy 0.5 shares of PRE.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.